Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07582042 · ClinicalTrials.gov registry record
Lesion-tailored, Fundus-controlled Perimetry in Geographic Atrophy (GA).
A clinical trial, sponsored by University of Utah.
- Recruiting
- Registry status
- 50
- Enrollment target
NCT07582042: Recruiting study, sponsored by University of Utah.
NCT07582042 is a clinical trial that is actively recruiting participants, run by University of Utah. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07582042 is actively recruiting participants, sponsored by University of Utah.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
Study Summary
The goal of this observational study is to evaluate changes in retinal sensitivity over time in patients with geographic atrophy due to age related macular degeneration who are receiving pegcetacoplan as part of routine clinical care. The study aims to determine whether lesion tailored fundus-controlled perimetry can reliably measure functional changes near areas of atrophy and whether this testing can be implemented in everyday clinic care over 24 months. Participants will undergo repeated vision testing, standard eye imaging, and visual function questionnaires while continuing their prescribed treatment.
Primary Outcome
Quantify rates of mesopic sensitivity decline over time at defined distances from the Geographic Atrophy (GA) boundary.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2026-06-15 |
| Est. Completion | 2029-08-01 |
What NCT07582042 shows while recruiting
NCT07582042 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT07582042 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07582042 about?
NCT07582042 is a clinical study titled "Lesion-tailored, Fundus-controlled Perimetry in Geographic Atrophy (GA).". The goal of this observational study is to evaluate changes in retinal sensitivity over time in patients with geographic atrophy due to age related macular degeneration who are receiving pegcetacoplan as part of routine clinical care. The study aims to determine whether lesion tailored fundus-contro...
What is the current status of trial NCT07582042?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2026-06-15. Estimated completion is 2029-08-01.
Who is sponsoring clinical trial NCT07582042?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI